Utah plans to allow an AI product to evaluate patients and write new drug prescriptions without prior human review.

Vaxcyte disclosed that its pneumococcal vaccine hit the primary endpoints in a Phase 3 clinical trial, setting up a ...

It is probably impossible to overstate how complex a brain is: A network of billions of intertwined neurons forming an ...

The Trump administration released new regulations Monday that will force health insurance companies to publish cleaned-up spreadsheets of the prices that they pay hospitals and do ...

Vaxcyte said its experimental pneumococcal vaccine hit the primary endpoints in a Phase 3 clinical trial, setting up the ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. WASHINGTON — The upcoming midterm ...

What science says so far about which cancers can be beat by vaccines — and which will require more creative approaches.

Jeremy Faust cuts through a hallway of Boston’s Brigham and Women’s Hospital on his way to see a patient who is struggling to breathe. It’s the start of his evening shift, and the emergency department ...

Merck discontinued Recarbio, an important antibiotic in the U.S., despite concerns over resistance to superbugs.

President Trump is promising more payments to voters just ahead of the Nov. 3 midterm elections — this time for seniors' Medicare Part B premiums ...

Congo's Ebola outbreak has killed more than 4,000 people, authorities said, as they struggle to contain what has become the ...